Ignite Creation Date:
2024-05-05 @ 11:26 AM
Last Modification Date:
2024-10-26 @ 9:08 AM
Study NCT ID:
NCT00048360
Status:
COMPLETED
Last Update Posted:
2013-02-12
First Post:
2002-10-30
Brief Title:
Attention-Deficit Hyperactivity Disorder ADHD Study With Adults
Sponsor:
GlaxoSmithKline
Organization:
GlaxoSmithKline
Study Overview
Official Title:
An 8-week Multicenter Randomized Double-Blind Placebo-Controlled Flexible-Dose Comparison of Extended-Release Bupropion Hydrochloride 300-450 mgDay to Assess the Efficacy Safety and Effects on Health Outcomes in the Treatment of Adults With Attention-DeficitHyperactivity Disorder
Status:
COMPLETED
Status Verified Date:
2013-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This is a placebo controlled study evaluating the efficacy and safety of medication in adults with Attention-Deficit Hyperactivity Disorder ADHD
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None